Wellington Management Group
GNMK

Wellington Management Group’s GenMark Diagnostics, Inc GNMK Stock Holding History

Wellington Management Group’s Portfolio GNMK Stock Details GNMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-34,458
Closed -$489K – 2053
2020
Q3 		$489K Buy
34,458
+16,568
+93% +$253K ﹤0.01% 1716
2020
Q2 		$263K Buy
+17,890
New +$182K ﹤0.01% 1769
2019
Q1 		– Sell
-697,752
Closed -$3.39M – 2160
2018
Q4 		$3.39M Buy
+697,752
New +$3.63M ﹤0.01% 1491

Other funds holding GNMK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group's GNMK Position: Q4 2020 in Review

Wellington Management Group sold out of GenMark Diagnostics, Inc (GNMK) in Q4 2020, closing a stake of 34,458 shares — an estimated $489K sold.

Wellington Management Group first reported a position in GNMK in Q4 2018 and held it in 3 quarters. The position peaked at $3.39M in Q4 2018. 151 funds tracked by Wall St. Rank hold GNMK as of Q4 2020.

  • Wellington Management Group reported no remaining GenMark Diagnostics, Inc position as of Q4 2020 after selling out during the quarter.
  • Wellington Management Group sold 34,458 GenMark Diagnostics, Inc shares in Q4 2020, an estimated $489K.
  • Wellington Management Group first reported a position in GenMark Diagnostics, Inc in Q4 2018 and held it in 3 quarters.
  • Wellington Management Group's GenMark Diagnostics, Inc position peaked at $3.39M in Q4 2018.
  • 151 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q4 2020.

Based on Wellington Management Group's 13F filing for Q4 2020, filed 12 Feb 2021.